BPC-157 (10mg): Cytoprotection and Angiogenesis BPC-157 is a synthetic 15-amino-acid pentadecapeptide derived from a human gastric juice protein
Aptamer-labeled PLGA nanoparticles for targeting cancer cells
One study reported that the scaffold protein phosphatidylethanolamine binding protein 1 (PEBP1) binds to 15-lipoxygenase (15LOX) and directs it to PUFAs in the membrane, thereby facilitating ferroptosis [81]
Lee HY, Choi YP, Kim S, Yoon T, Guo Z, Lee S et al
NNC 26-0161 was the development designation used during Novo Nordisk pharmaceutical work
BPC-157 does not directly improve sleep through hormonal mechanisms, though reducing chronic pain or inflammation may indirectly improve sleep quality in patients whose sleep is disrupted by physical discomfort